BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22089093)

  • 1. Pathogenesis of ANCA-associated vasculitis: recent insights from animal models.
    van Timmeren MM; Heeringa P
    Curr Opin Rheumatol; 2012 Jan; 24(1):8-14. PubMed ID: 22089093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of ANCA-associated vasculitides.
    Kallenberg CG
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i59-63. PubMed ID: 21339221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 2 induces Th17 myeloperoxidase autoimmunity while Toll-like receptor 9 drives Th1 autoimmunity in murine vasculitis.
    Summers SA; Steinmetz OM; Gan PY; Ooi JD; Odobasic D; Kitching AR; Holdsworth SR
    Arthritis Rheum; 2011 Apr; 63(4):1124-35. PubMed ID: 21190299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
    Nakazawa D; Tomaru U; Suzuki A; Masuda S; Hasegawa R; Kobayashi T; Nishio S; Kasahara M; Ishizu A
    Arthritis Rheum; 2012 Nov; 64(11):3779-87. PubMed ID: 22777766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A; Xiao H; Falk RJ; Jennette JC
    J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
    Csernok E; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of small vessel vasculitis associated with autoantibodies to neutrophil cytoplasmic antigens: new insights from animal models.
    Kain R; Firmin DA; Rees AJ
    Curr Opin Rheumatol; 2010 Jan; 22(1):15-20. PubMed ID: 19823088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Coughlan AM; Freeley SJ; Robson MG
    Clin Exp Immunol; 2012 Sep; 169(3):229-37. PubMed ID: 22861362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
    Tervaert JW; Heeringa P
    Neth J Med; 2003 Dec; 61(12):404-7. PubMed ID: 15025415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of ANCA-associated vasculitis, an update.
    Kallenberg CG
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):224-31. PubMed ID: 21336557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jennette JC; Falk RJ
    Curr Opin Rheumatol; 2008 Jan; 20(1):55-60. PubMed ID: 18281858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent pathogenetic advances in ANCA-associated vasculitis.
    Pendergraft WF; Nachman PH
    Presse Med; 2015 Jun; 44(6 Pt 2):e223-9. PubMed ID: 26033562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of systemic vasculitis.
    Mathieson PW; Qasim FJ; Esnault VL; Oliveira DB
    J Autoimmun; 1993 Apr; 6(2):251-64. PubMed ID: 8388693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANCA-small vessel vasculitides: what have we (not yet) learned from animal models?
    van der Veen BS; Heeringa P
    APMIS Suppl; 2009 Jun; (127):21-6. PubMed ID: 19515135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial infections in Wegener's granulomatosis: mechanisms potentially involved in autoimmune pathogenesis.
    Tadema H; Heeringa P; Kallenberg CG
    Curr Opin Rheumatol; 2011 Jul; 23(4):366-71. PubMed ID: 21494184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: Pathogenic role of complement activation in anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
    Van Timmeren MM; Chen M; Heeringa P
    Nephrology (Carlton); 2009 Feb; 14(1):16-25. PubMed ID: 19335841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
    Jennette JC; Xiao H; Falk RJ
    J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner.
    Hoshino A; Nagao T; Nagi-Miura N; Ohno N; Yasuhara M; Yamamoto K; Nakayama T; Suzuki K
    J Autoimmun; 2008 Aug; 31(1):79-89. PubMed ID: 18501296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The complement system in the pathogenesis of antineutrophil cytoplasm antibodies-associated vasculitis].
    Flores-Suárez LF
    Reumatol Clin; 2011 Dec; 7 Suppl 3():S18-21. PubMed ID: 22152286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.